Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Vedolizumab for induction and maintenance of remission in Crohn’s disease

This protocol has been withdrawn

Information

DOI:
https://doi.org/10.1002/14651858.CD011615.pub2Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 01 November 2017see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:
  1. Cochrane Gut Group

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Reena Khanna

    Department of Medicine, University of Western Ontario, London, Canada

    Robarts Clinical Trials, London, Canada

  • Mahmoud H Mosli

    King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia

  • Mindy CW Lam

    Division of Gastroenterology, University of British Columbia, Vancouver, Canada

  • Nancy Fu

    Department of Medicine, University of British Columbia, Vancouver, Canada

  • Brian Bressler

    Division of Gastroenterology, University of British Columbia, Vancouver, Canada

  • Greg Rosenfeld

    Division of Gastroenterology, University of British Columbia, Vancouver, Canada

  • John K MacDonald

    Department of Medicine, University of Western Ontario, London, Canada

    Cochrane IBD Group, Robarts Clinical Trials, London, Canada

  • Barrett G Levesque

    Robarts Clinical Trials, San Diego, USA

  • Brian G Feagan

    Correspondence to: Cochrane IBD Group, Robarts Clinical Trials, London, Canada

    [email protected]

Version history

Published

Title

Stage

Authors

Version

2017 Nov 01

Vedolizumab for induction and maintenance of remission in Crohn’s disease

Protocol

Reena Khanna, Mahmoud H Mosli, Mindy CW Lam, Nancy Fu, Brian Bressler, Greg Rosenfeld, John K MacDonald, Barrett G Levesque, Brian G Feagan

https://doi.org/10.1002/14651858.CD011615.pub2

2015 Mar 26

Vedolizumab for induction and maintenance of remission in Crohn’s disease

Protocol

Reena Khanna, Mahmoud H Mosli, Mindy CW Lam, Nancy Fu, Brian Bressler, Greg Rosenfeld, John K MacDonald, Barrett G Levesque, Brian G Feagan

https://doi.org/10.1002/14651858.CD011615